Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SYNALAR BI-OTIC SOLUTION 3.5 MG

NEOMYCIN (NEOMYCIN SULFATE) : 3.5 MG FLUOCINOLONE ACETONIDE : 0.25 MG POLYMYXIN B SULFATE : 10000 UNIT · DIN 00189499 · MEDICIS CANADA LTD.

Health Canada status: CANCELLED POST MARKET

What is SYNALAR BI-OTIC SOLUTION?

SYNALAR BI-OTIC SOLUTION 3.5 MG contains NEOMYCIN (NEOMYCIN SULFATE) : 3.5 MG FLUOCINOLONE ACETONIDE : 0.25 MG POLYMYXIN B SULFATE : 10000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00189499, held by MEDICIS CANADA LTD., supplied as SOLUTION for OTIC administration. Health Canada currently lists it as cancelled post market, status dated 25-Sep-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00189499
Brand nameSYNALAR BI-OTIC SOLUTION
Generic / active ingredientNEOMYCIN (NEOMYCIN SULFATE) : 3.5 MG FLUOCINOLONE ACETONIDE : 0.25 MG POLYMYXIN B SULFATE : 10000 UNIT
ManufacturerMEDICIS CANADA LTD.
Strength3.5 MG
Dosage formSOLUTION
Route of administrationOTIC
SchedulePrescription
ATC codeS02CA05 FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES
AHFS class52:04.04 ; 52:08.00
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date25-Sep-1998
Original market date1986-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code S02CA05 FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
OTIXAL0.3 %SOLUTIONMEDEXUS PHARMACEUTICALS INC.MARKETEDDIN 02459655

Who else supplies FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FLUOCINOLONE ACETONIDE AND ANTIINFECTIVES appears in 4 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for SYNALAR BI-OTIC SOLUTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for SYNALAR BI-OTIC SOLUTION

Health Canada Drug Product Database (DPD), DIN 00189499. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.